Personalized Cancer Vaccines Global Market Report 2024

Global Personalized Cancer Vaccines Market Report 2024

Personalized Cancer Vaccines Global Market Report 2024 – By Treatment Type (Preventive Cancer Vaccines, Therapeutic Cancer Vaccines), By Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Prostate Cancer, Cervical Cancer, Glioblastoma), By Mechanism Of Action (Tumor Associated Antigens (TAAs), Tumor Specific Antigens (TSAs), Somatic Mutations In Cancer Pharmacogenomics, Pharmacogenomics Towards Genomic Polymorphism, Other Mechanisms Of Action), By Route Of Administration (Injectables, Other Routes Of Administration), By End Use (Hospitals, Clinic, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

Name: Personalized Cancer Vaccines Global Market Report 2024
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Personalized Cancer Vaccines Global Market Report 2024

Starting Price : $5000.00 $4000.00 | Pages : 175 | Published : November 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Global Personalized Cancer Vaccines Market Infographic

Proud Members Of

Personalized Cancer Vaccines Market Definition

Personalized cancer vaccines refer to treatments tailored to an individual's unique tumor profile, aiming to stimulate their immune system to target and destroy cancer cells. They improve the body's ability to recognize and fight specific cancer types, potentially enhancing treatment efficacy and reducing recurrence.

The main types of personalized cancer vaccines are preventive cancer vaccines and therapeutic cancer vaccines. Preventive cancer vaccines are designed to protect against infections or conditions that may lead to cancer. It is used to treat various cancer types, including lung cancer, breast cancer, colorectal cancer, leukemia, prostate cancer, cervical cancer, and glioblastoma, through different mechanisms of action, including tumor-associated antigens (TAAS), tumor-specific antigens (TSAS), somatic mutations in cancer pharmacogenomics, pharmacogenomics towards genomic polymorphism, and others. It is provided through varying routes of administration, which include injectables and others in different end uses, such as hospitals, clinics, and others.

Personalized Cancer Vaccines Market Segmentation

The personalized cancer vaccines market covered in this report is segmented –

1) By Treatment Type: Preventive Cancer Vaccines, Therapeutic Cancer Vaccines

2) By Cancer Type: Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Prostate Cancer, Cervical Cancer, Glioblastoma

3) By Mechanism Of Action: Tumor Associated Antigens (TAAs), Tumor Specific Antigens (TSAs), Somatic Mutations In Cancer Pharmacogenomics, Pharmacogenomics Towards Genomic Polymorphism, Other Mechanisms Of Action

4) By Route Of Administration: Injectables, Other Routes Of Administration

5) By End Use: Hospitals, Clinic, Other End Users

Global Personalized Cancer Vaccines Market Size 2023 to 2028: Graph

Personalized Cancer Vaccines Market Size 2024 And Growth Rate

The personalized cancer vaccines market size has grown strongly in recent years. It will grow from $227.31 billion in 2023 to $242.29 billion in 2024 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to advancements in genomic research, development of targeted therapies, increased understanding of tumor immunology, progress in vaccine technology and growing clinical trial data supporting efficacy.

Personalized Cancer Vaccines Market Growth Forecast

The personalized cancer vaccines market size is expected to see strong growth in the next few years. It will grow to $315.16 billion in 2028 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to advancements in precision medicine, increasing funding for cancer research, rising prevalence of cancer cases, improvements in genetic sequencing technologies and growing interest in personalized treatment options. Major trends in the forecast period include the integration of artificial intelligence in vaccine design, advances in multi-antigen and neoantigen-based vaccines, increased use of liquid biopsies for tumor monitoring, expansion of combination therapies, and greater focus on personalized treatment regimens.

Book your 30 minutes free consultation with our research experts

Personalized Cancer Vaccines Market Driver: Increasing Cancer Incidence Accelerates Demand For Targeted Immunotherapies

The increasing prevalence of cancer is expected to propel the growth of the personalized cancer vaccine market going forward. Cancer refers to a collection of diseases marked by abnormal cell growth that can spread to other parts of the body. The increasing prevalence of cancer is due to aging populations, lifestyle changes, environmental pollutants, genetic predispositions, and improved diagnostic techniques. Personalized cancer vaccines help prevent the increasing prevalence of cancer by targeting specific tumor antigens unique to each patient, enhancing the immune system's ability to recognize and destroy cancer cells. For instance, in July 2024, according to the Australian Institute of Health and Welfare, an Australia-based government agency, in Australia the number of cancer cases diagnosed increased from 160,570 in 2022 to 164,694 in 2023, reflecting a notable rise over the year. Therefore, the increasing prevalence of cancer is driving the growth of the personalized cancer vaccine market.

Global Personalized Cancer Vaccines Market Major Players

Major companies operating in the personalized cancer vaccines market are Merck & Co Inc., GlaxoSmithKline Plc, NEC Corporation, Moderna Inc., Catalent Inc., UCLA Health, Genetech Inc., NHS England, CureVac AG, Personalis Inc., Achilles Therapeutics Plc, Healio, Moffitt Corporation, BioPharma APAC, Celebrity Angels, EpiVax Therapeutics Inc., Evaxion Biotech AS, Geneos Therapeutics Inc., IFL Sciense, ISA Pharmaceuticals BV, Oxford Global, Kintara Therapeutics, VAXIMM Gmbh

Global Personalized Cancer Vaccines Market Trend: Innovative Therapies Target Specific Cancer Mutations For Enhanced Treatment

Major companies operating in the personalized cancer vaccine market are focused on developing advanced therapeutic solutions, such as personalized immunotherapy, to enhance precision in treating specific cancer mutations. Personalized immunotherapy solutions are customized treatments designed to use a patient's unique genetic and tumor characteristics to improve immune system responses against cancer. For instance, in August 2024, UCLA Health, a US-based healthcare organization, launched a first-of-its-kind clinical trial to evaluate the safety and effectiveness of a cancer vaccine. The vaccine developed at UCLA leverages a personalized immunotherapy approach that targets the H3 G34 mutation in diffuse hemispheric gliomas, a highly aggressive brain tumor often found in adolescents and young adults. It uniquely utilizes dendritic cells to activate the immune system against the specific RNA disruptions caused by this mutation. The approach, which has shown promise in treating other cancers, aims to improve outcomes for patients who typically face limited treatment options and short survival times.

Personalized Cancer Vaccines Market Merger And Acquisition: NEC Oncoimmunity AS Enhances Personalized Therapy Development With VAXIMM Acquisition

In March 2022, NEC OncoImmunity AS, a Norway-based biotechnology company, acquired neoantigen program assets from VAXIMM Gmbh for an undisclosed amount. Through this acquisition, NEC OncoImmunity (NOI) aims to strengthen its neoantigen cancer vaccine development, including patents and existing collaboration agreements. This move will enhance NOI's ability to advance personalized cancer immunotherapies, building on their previous collaboration with VAXIMM. VAXIMM GmbH is a Germany-based biopharmaceutical company that focuses on creating personalized cancer vaccines.

Regional Insights For The Global Personalized Cancer Vaccines Market

North America was the largest region in the personalized cancer vaccines market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the personalized cancer vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the personalized cancer vaccines market report areAustralia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The personalized cancer vaccines market consists of sales of patient-specific vaccines, neoantigen-based therapies, dendritic cell-based vaccines and peptide-based immunotherapies. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The personalized cancer vaccines market research report is one of a series of new reports from The Business Research Company that provides personalized cancer vaccines market statistics, including personalized cancer vaccines industry global market size, regional shares, competitors with a personalized cancer vaccines market share, detailed personalized cancer vaccines market segments, market trends and opportunities, and any further data you may need to thrive in the personalized cancer vaccines industry. This personalized cancer vaccines market research report delivers a complete perspective on everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Personalized Cancer Vaccines Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2024	$242.29 billion
Revenue Forecast In 2033	$315.16 billion
Growth Rate	CAGR of 6.8% from 2024 to 2033
Base Year For Estimation	2023
Actual Estimates/Historical Data	2018-2023
Forecast Period	2024 - 2028 - 2033
Market Representation	Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered	1) By Treatment Type: Preventive Cancer Vaccines; Therapeutic Cancer Vaccines 2) By Cancer Type: Lung Cancer; Breast Cancer; Colorectal Cancer; Leukemia; Prostate Cancer; Cervical Cancer; Glioblastoma 3) By Mechanism Of Action: Tumor Associated Antigens (TAAs); Tumor Specific Antigens (TSAs); Somatic Mutations In Cancer Pharmacogenomics; Pharmacogenomics Towards Genomic Polymorphism; Other Mechanisms Of Action 4) By Route Of Administration: Injectables; Other Routes Of Administration 5) By End Use: Hospitals; Clinic; Other End Users
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Merck & Co Inc, GlaxoSmithKline Plc, NEC Corporation, Moderna Inc, Catalent Inc, UCLA Health, Genetech Inc, NHS England, CureVac AG, Personalis Inc, Achilles Therapeutics Plc, Healio, Moffitt Corporation, BioPharma APAC, Celebrity Angels, EpiVax Therapeutics Inc., Evaxion Biotech AS, Geneos Therapeutics Inc, IFL Sciense, ISA Pharmaceuticals BV, Oxford Global, Kintara Therapeutics, VAXIMM Gmbh
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Personalized Cancer Vaccines Market Characteristics

3. Personalized Cancer Vaccines Market Trends And Strategies

4. Personalized Cancer Vaccines Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market

4.2. Ukraine-Russia War Impact On The Market

4.3. COVID-19 Impact On The Market

5. Global Personalized Cancer Vaccines Market Size and Growth

5.1. Global Personalized Cancer Vaccines Market Drivers and Restraints

5.1.1. Drivers Of The Market

5.1.2. Restraints Of The Market

5.2. Global Personalized Cancer Vaccines Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

5.3. Global Personalized Cancer Vaccines Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Personalized Cancer Vaccines Market Segmentation

6.1. Global Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Preventive Cancer Vaccines

Therapeutic Cancer Vaccines

6.2. Global Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Lung Cancer

Breast Cancer

Colorectal Cancer

Leukemia

Prostate Cancer

Cervical Cancer

Glioblastoma

6.3. Global Personalized Cancer Vaccines Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Tumor Associated Antigens (TAAs)

Tumor Specific Antigens (TSAs)

Somatic Mutations In Cancer Pharmacogenomics

Pharmacogenomics Towards Genomic Polymorphism

Other Mechanisms Of Action

6.4. Global Personalized Cancer Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Injectables

Other Routes Of Administration

6.5. Global Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Hospitals

Clinic

Other End Users

7. Personalized Cancer Vaccines Market Regional And Country Analysis

7.1. Global Personalized Cancer Vaccines Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

7.2. Global Personalized Cancer Vaccines Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Personalized Cancer Vaccines Market

8.1. Asia-Pacific Personalized Cancer Vaccines Market Overview

Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8.3. Asia-Pacific Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8.4. Asia-Pacific Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Personalized Cancer Vaccines Market

9.1. China Personalized Cancer Vaccines Market Overview

9.2. China Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

9.3. China Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

9.4. China Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Personalized Cancer Vaccines Market

10.1. India Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10.2. India Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10.3. India Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Personalized Cancer Vaccines Market

11.1. Japan Personalized Cancer Vaccines Market Overview

11.2. Japan Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11.3. Japan Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11.4. Japan Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Personalized Cancer Vaccines Market

12.1. Australia Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12.2. Australia Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12.3. Australia Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Personalized Cancer Vaccines Market

13.1. Indonesia Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13.2. Indonesia Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13.3. Indonesia Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Personalized Cancer Vaccines Market

14.1. South Korea Personalized Cancer Vaccines Market Overview

14.2. South Korea Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14.3. South Korea Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14.4. South Korea Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Personalized Cancer Vaccines Market

15.1. Western Europe Personalized Cancer Vaccines Market Overview

15.2. Western Europe Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15.3. Western Europe Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15.4. Western Europe Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Personalized Cancer Vaccines Market

16.1. UK Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16.2. UK Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16.3. UK Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Personalized Cancer Vaccines Market

17.1. Germany Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17.2. Germany Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17.3. Germany Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Personalized Cancer Vaccines Market

18.1. France Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18.2. France Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18.3. France Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Personalized Cancer Vaccines Market

19.1. Italy Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19.2. Italy Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19.3. Italy Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Personalized Cancer Vaccines Market

20.1. Spain Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20.2. Spain Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20.3. Spain Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Personalized Cancer Vaccines Market

21.1. Eastern Europe Personalized Cancer Vaccines Market Overview

21.2. Eastern Europe Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21.3. Eastern Europe Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21.4. Eastern Europe Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Personalized Cancer Vaccines Market

22.1. Russia Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22.2. Russia Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22.3. Russia Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Personalized Cancer Vaccines Market

23.1. North America Personalized Cancer Vaccines Market Overview

23.2. North America Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23.3. North America Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23.4. North America Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Personalized Cancer Vaccines Market

24.1. USA Personalized Cancer Vaccines Market Overview

24.2. USA Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24.3. USA Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24.4. USA Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Personalized Cancer Vaccines Market

25.1. Canada Personalized Cancer Vaccines Market Overview

25.2. Canada Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25.3. Canada Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25.4. Canada Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Personalized Cancer Vaccines Market

26.1. South America Personalized Cancer Vaccines Market Overview

26.2. South America Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26.3. South America Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26.4. South America Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Personalized Cancer Vaccines Market

27.1. Brazil Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27.2. Brazil Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27.3. Brazil Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Personalized Cancer Vaccines Market

28.1. Middle East Personalized Cancer Vaccines Market Overview

28.2. Middle East Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28.3. Middle East Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28.4. Middle East Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Personalized Cancer Vaccines Market

29.1. Africa Personalized Cancer Vaccines Market Overview

29.2. Africa Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29.3. Africa Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29.4. Africa Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Personalized Cancer Vaccines Market Competitive Landscape And Company Profiles

30.1. Personalized Cancer Vaccines Market Competitive Landscape

30.2. Personalized Cancer Vaccines Market Company Profiles

30.2.1. Merck & Co Inc

30.2.1.1. Overview

30.2.1.2. Products and Services

30.2.1.3. Strategy

30.2.1.4. Financial Performance

30.2.2. GlaxoSmithKline Plc

30.2.2.1. Overview

30.2.2.2. Products and Services

30.2.2.3. Strategy

30.2.2.4. Financial Performance

30.2.3. NEC Corporation

30.2.3.1. Overview

30.2.3.2. Products and Services

30.2.3.3. Strategy

30.2.3.4. Financial Performance

30.2.4. Moderna Inc

30.2.4.1. Overview

30.2.4.2. Products and Services

30.2.4.3. Strategy

30.2.4.4. Financial Performance

30.2.5. Catalent Inc

30.2.5.1. Overview

30.2.5.2. Products and Services

30.2.5.3. Strategy

30.2.5.4. Financial Performance

31. Personalized Cancer Vaccines Market Other Major And Innovative Companies

31.1. UCLA Health

31.2. Genetech Inc

31.3. NHS England

31.4. CureVac AG

31.5. Personalis Inc

31.6. Achilles Therapeutics Plc

31.7. Healio

31.8. Moffitt Corporation

31.9. BioPharma APAC

31.10. Celebrity Angels

31.11. EpiVax Therapeutics Inc.

31.12. Evaxion Biotech AS

31.13. Geneos Therapeutics Inc

31.14. IFL Sciense

31.15. ISA Pharmaceuticals BV

32. Global Personalized Cancer Vaccines Market Competitive Benchmarking

33. Global Personalized Cancer Vaccines Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Personalized Cancer Vaccines Market

35. Personalized Cancer Vaccines Market Future Outlook and Potential Analysis

35.1 Personalized Cancer Vaccines Market In 2028 - Countries Offering Most New Opportunities

35.2 Personalized Cancer Vaccines Market In 2028 - Segments Offering Most New Opportunities

35.3 Personalized Cancer Vaccines Market In 2028 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2018-2023, $ Billion

Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion

Table 3: Global Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 4: Global Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 5: Global Personalized Cancer Vaccines Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 6: Global Personalized Cancer Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 7: Global Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 8: Global Personalized Cancer Vaccines Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 9: Global Personalized Cancer Vaccines Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 10: Asia-Pacific, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 11: Asia-Pacific, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 12: Asia-Pacific, Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 13: China, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 14: China, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 15: China, Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 16: India, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 17: India, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 18: India, Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 19: Japan, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 20: Japan, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 21: Japan, Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 22: Australia, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 23: Australia, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 24: Australia, Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 25: Indonesia, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 26: Indonesia, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 27: Indonesia, Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 28: South Korea, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 29: South Korea, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 30: South Korea, Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 31: Western Europe, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 32: Western Europe, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 33: Western Europe, Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 34: UK, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 35: UK, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 36: UK, Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 37: Germany, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 38: Germany, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 39: Germany, Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 40: France, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 41: France, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 42: France, Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 43: Italy, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 44: Italy, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 45: Italy, Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 46: Spain, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 47: Spain, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 48: Spain, Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 49: Eastern Europe, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 50: Eastern Europe, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 51: Eastern Europe, Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 52: Russia, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 53: Russia, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 54: Russia, Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 55: North America, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 56: North America, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 57: North America, Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 58: USA, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 59: USA, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 60: USA, Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 61: Canada, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 62: Canada, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 63: Canada, Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 64: South America, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 65: South America, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 66: South America, Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 67: Brazil, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 68: Brazil, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 69: Brazil, Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 70: Middle East, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 71: Middle East, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 72: Middle East, Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 73: Africa, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 74: Africa, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 75: Africa, Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 76: Merck & Co Inc Financial Performance

Table 77: GlaxoSmithKline Plc Financial Performance

Table 78: NEC Corporation Financial Performance

Table 79: Moderna Inc Financial Performance

Table 80: Catalent Inc Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2018-2023, $ Billion

Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion

Figure 3: Global Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 4: Global Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 5: Global Personalized Cancer Vaccines Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 6: Global Personalized Cancer Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 7: Global Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 8: Global Personalized Cancer Vaccines Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 9: Global Personalized Cancer Vaccines Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 10: Asia-Pacific, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 11: Asia-Pacific, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 12: Asia-Pacific, Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 13: China, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 14: China, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 15: China, Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 16: India, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 17: India, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 18: India, Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 19: Japan, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 20: Japan, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 21: Japan, Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 22: Australia, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 23: Australia, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 24: Australia, Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 25: Indonesia, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 26: Indonesia, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 27: Indonesia, Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 28: South Korea, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 29: South Korea, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 30: South Korea, Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 31: Western Europe, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 32: Western Europe, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 33: Western Europe, Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 34: UK, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 35: UK, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 36: UK, Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 37: Germany, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 38: Germany, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 39: Germany, Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 40: France, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 41: France, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 42: France, Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 43: Italy, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 44: Italy, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 45: Italy, Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 46: Spain, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 47: Spain, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 48: Spain, Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 49: Eastern Europe, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 50: Eastern Europe, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 51: Eastern Europe, Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 52: Russia, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 53: Russia, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 54: Russia, Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 55: North America, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 56: North America, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 57: North America, Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 58: USA, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 59: USA, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 60: USA, Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 61: Canada, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 62: Canada, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 63: Canada, Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 64: South America, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 65: South America, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 66: South America, Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 67: Brazil, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 68: Brazil, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 69: Brazil, Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 70: Middle East, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 71: Middle East, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 72: Middle East, Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 73: Africa, Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 74: Africa, Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 75: Africa, Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 76: Merck & Co Inc Financial Performance

Figure 77: GlaxoSmithKline Plc Financial Performance

Figure 78: NEC Corporation Financial Performance

Figure 79: Moderna Inc Financial Performance

Figure 80: Catalent Inc Financial Performance

Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company

Global Gene Therapy Market 2022 – Market Opportunities And Strategies

The Microbiome Market Share, Market Size, And Growth Rate 2022

Latest TNF Alpha Inhibitors Market Growth Study 2022-2026 By The Business Research Company

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the dermatitis market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the insulin drugs market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the anti-parkinson drugs market research report 2022 with industry size, share, segments and market growth

Cancer Vaccines Global Market Report 2024 – By Type (Preventive Cancer Vaccines, Therapeutic Cancer Vaccines), By Technology (Dendritic Cells (DC) Cancer Vaccines, Recombinant Cancer Vaccines, Antigen/Adjuvant Cancer Vaccines, Whole Cell Cancer Vaccines, Viral Vector & DNA Cancer Vaccines), By Cancer Type (Prostate, Cervical, Colorectal, Throat, Other Cancer Types), By End-User (Cancer Treatment Centers, Research Institutes) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Cervical Cancer Vaccine Global Market Report 2024 – By Type (Cervarix, Gardasil, Gardasil 9), By Distribution Channels (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By End-Users (Hospital, Biotechnology Company, Academic And Research Organizations, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Cancer biologics Global Market Report 2024 – By Type (Monoclonal Antibodies, Vaccines, Cell And Gene Therapy, Other Types), By Application (Non-small Cell Lung Cancer, Prostate Cancer, Breast Cancer, Acute Myeloid Leukemia, Lymphoma, Multiple Myeloma, Ovarian Cancer, Colorectal Cancer, Gastric Cancers, Other Applications), By Distribution Channel (Hospitals, Clinics, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Cancer Profiling Global Market Report 2024 – By Technology (Immunoassays, PCR (Polymerized Chain Reaction), NGS (Next-Generation Sequencing), Microarrays, In-Situ Hybridization), By Biomarker Type (Genomic Biomarkers, Protein Biomarkers), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma Cancer, Other Cancers), By Application (Research Applications, Clinical Applications, Screening, Diagnostics, Prognostics, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Esophageal Cancer Global Market Report 2024 – By Type (Esophageal Squamous-Cell Carcinoma, Esophageal Adenocarcinoma, Other Types), By Treatment Type (Chemotherapy, Targeted Therapy, Other Treatment Types), By Route Of Administration (Oral, Parenteral, Other Routes Of Administration), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), By End Users (Hospitals, Homecare, Specialty Centers, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Intestine Cancer Therapeutics Global Market Report 2024 – By Treatment Type (Immunotherapy, Chemotherapy, Other Treatments), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), By Application (Hospitals, Homecare, Specialty Centers, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Personalized Nutrition Global Market Report 2024 – By Product Type (Personalized Supplements, Personalized Diet Plans, Personalized Beverages, Diseases Based), By Form (Tablets, Capsules, Powder, Liquid, Other Forms), By Measurement Method (Active Measurements, Standard Measurements), By End User (Direct-To-Consumer, Wellness And Fitness Centers, Hospitals And Clinics, Institutions, Food Delivery Services) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Personalized Medicine Global Market Report 2024 – By Product (Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, Personalized Medical Care, Personalized Nutrition and Wellness), By Application (Oncology, Neurology, Blood Transfusion Safety, Diabetes, Autoimmune Diseases, Cardiology, Other Applications), By End-use (Hospitals, Diagnostic Centers, Research and Academic Institutes, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Frequently Asked Questions

What is the definition of the personalized cancer vaccines market?

How will the personalized cancer vaccines market drivers and restraints affect the personalized cancer vaccines market dynamics? What forces will shape the personalized cancer vaccines industry going forward?

The personalized cancer vaccines market major growth driver - Increasing Cancer Incidence Accelerates Demand For Targeted Immunotherapies. For further insights on the personalized cancer vaccines market, request a sample here

What is the forecast market size or the forecast market value of the personalized cancer vaccines market?

The personalized cancer vaccines market size has grown strongly in recent years. It will grow from $227.31 billion in 2023 to $242.29 billion in 2024 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to advancements in genomic research, development of targeted therapies, increased understanding of tumor immunology, progress in vaccine technology and growing clinical trial data supporting efficacy. The personalized cancer vaccines market size is expected to see strong growth in the next few years. It will grow to $315.16 billion in 2028 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to advancements in precision medicine, increasing funding for cancer research, rising prevalence of cancer cases, improvements in genetic sequencing technologies and growing interest in personalized treatment options. Major trends in the forecast period include the integration of artificial intelligence in vaccine design, advances in multi-antigen and neoantigen-based vaccines, increased use of liquid biopsies for tumor monitoring, expansion of combination therapies, and greater focus on personalized treatment regimens. For further insights on the personalized cancer vaccines market, request a sample here

How is the personalized cancer vaccines market segmented?

The personalized cancer vaccines market is segmented
1) By Treatment Type: Preventive Cancer Vaccines, Therapeutic Cancer Vaccines
2) By Cancer Type: Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Prostate Cancer, Cervical Cancer, Glioblastoma
3) By Mechanism Of Action: Tumor Associated Antigens (TAAs), Tumor Specific Antigens (TSAs), Somatic Mutations In Cancer Pharmacogenomics, Pharmacogenomics Towards Genomic Polymorphism, Other Mechanisms Of Action
4) By Route Of Administration: Injectables, Other Routes Of Administration
5) By End Use: Hospitals, Clinic, Other End UsersFor further insights on the personalized cancer vaccines market, request a sample here

Which region has the largest share of the personalized cancer vaccines market? What are the other regions covered in the report?

North America was the largest region in the personalized cancer vaccines market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the personalized cancer vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the personalized cancer vaccines market, request a sample here.

Who are the major players in the personalized cancer vaccines market?

What are the key trends in the personalized cancer vaccines market?

Major trend in the personalized cancer vaccines market - Innovative Therapies Target Specific Cancer Mutations For Enhanced Treatment. For further insights on the personalized cancer vaccines market, request a sample here.

What are the major opportunities in the personalized cancer vaccines market? What are the strategies for the personalized cancer vaccines market?

For detailed insights on the major opportunities and strategies in the personalized cancer vaccines market, request a sample here.

How does the personalized cancer vaccines market relate to the overall economy and other similar markets?

For detailed insights on personalized cancer vaccines market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the personalized cancer vaccines industry?

For detailed insights on the mergers and acquisitions in the personalized cancer vaccines industry, request a sample here.

What are the key dynamics influencing the personalized cancer vaccines market growth? SWOT analysis of the personalized cancer vaccines market.

For detailed insights on the key dynamics influencing the personalized cancer vaccines market growth and SWOT analysis of the personalized cancer vaccines industry, request a sample here.